Table 4.
NRI and IDI Analysis Between GOLD 2023 ABE Group and GOLD 2017 ABCD Group in Mortality Prediction in COPD
Item | Estimate | 95% Confidence Interval | P-value |
---|---|---|---|
Mortality (ABE VS ABCD) | |||
IDI | −0.001 | −0.002–0 | 0.010* |
NRI (continuous) | −0.160 | −0.239–0.064 | <0.001* |
Mortality (A1-E1 VS A1-D4) | |||
IDI | 0.001 | 0–0.003 | 0.100 |
NRI (continuous) | 0.138 | −0.065–0.197 | 0.269 |
Notes: * Statistical significance was determined at a P-value less than 0.05.
Abbreviations: NRI, net reclassification improvement; IDI, integrated discrimination improvement.